Atlas Biomed Group

Atlas Biomedical Holding is engaged in the development of a network of private medical centers and biomedical developments in the field of molecular genetics and bioinformatics.

The mission of Atlas Holding is to create and introduce personalized medicine tools into clinical practice.

Holding structure

• the platform for scientific development, creation of products and services of the holding is the research company Atlas Biomed Research.

• the clinical core of the holding is the Atlas Medical Center personalized medicine clinic.

• Atlas Oncology Diagnostic, a separate company in the field of oncogenetics.

• The scientific and educational project atlasmed as part of the holding includes an online magazine and an educational course on personalized medicine.

History

2024: Vadim Yakunin's purchase of 70% of the cancer laboratory from Atlas Holding

At the end of June 2024, it became known that the Atlas biomedical holding sold a 71.5 percent stake in the Oncoatlas molecular oncology center. The buyer was Vadim Yakunin, the main owner of the Protek group of companies. Read more here.

2022: Japan Market Entry

In mid-February 2022, it became known about the creation by the Russian biomedical holding Atlas of a company in Japan to sell its genetic and microbiota tests there to study the bacterial composition of the intestinal environment. As the founder and general director of the holding Sergey Musienko told Vedomosti, the Japanese subsidiary - Atlas Japan GK - was registered in 2021, at the same time the office of the new company was launched. Read more here.

2020: Sale of the Atlas clinic for 110 million rubles

At the end of June 2020, it became known about the sale of the Atlas clinic to the Protek group, which includes the Rigla, Be Healthy and Zhivika pharmacy chains. The transaction cost amounted to 110 million rubles. Read more here.

2015: Atlas receives IBM grant

On November 30, 2015, the press service of the Atlas biomedical holding announced the victory in the competition for the most promising company in the field of biotechnology and medicine, organized by IBM as part of the Open Innovations forum.

The competition is organized as part of the IBM Global Entrepreneur program - it identifies the most innovative companies around the world.

At the ceremony of determining the winner of the IBM competition (2015)

According to the results of the competition, Atlas Holding received access to IBM's mentoring program, which includes the best experts around the world and a grant of $120 thousand for access to IBM Watson technologies.

Watson technologies will allow the Atlas medical holding, which is the only company in Russia operating at the intersection of practical medicine, bioinformatics and genetics, to personalize the services provided at all stages of the patient's life path from the moment of diagnosis to the moment of complete recovery and rehabilitation.

Such cooperation creates a technological advantage in the Russian market and provides an opportunity to integrate the knowledge of Atlas Holding into future IBM healthcare solutions.

Pavel Shklyudov, leader of advanced technology for IBM's European Region, said:

- Watson has a unique ability to answer naturally asked questions, not using already prepared answers, but attracting the full amount of knowledge on a specific topic to solve problems and using all the capabilities of extensive databases collected around the world. Watson has given impetus to many developments using cognitive elements to enhance and personalize user relationships. Programs using Watson technologies can not only analyze databases, but also find correlations, propose hypotheses, even learn from the proposed examples.

Andrei Perfiliev, medical director of the holding, said:

- We are excited to be able to use unique computing power and applications to improve human health and accelerate scientific developments in biomedicine. By implementing all these areas, we gain unique experience and improve our expertise in working with big data in the field. health care Collaboration IBM with opens up a number of possibilities for conducting more accurate analysis, finding new relationships and building predictive models based on omix data.

Sergey Musienko, General Director of Atlas Holding, said:

- In the near future, Atlas will begin work on integrating Watson applications and services with a personal account on the site Atlas.ru. Thus, we will be able to make even more accurate practical recommendations on lifestyle changes and disease prevention based on the results of a genetic test and medical research data.